Clinical Trials Related to Acute Lymphoblastic Leukemia

Related studies linked through entity extraction aliases.

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

Status: RECRUITING
Phase: N/A

Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.

Status: COMPLETED
Phase: NA

Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology

Status: COMPLETED
Phase: N/A

Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone

Status: WITHDRAWN
Phase: PHASE1

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

Status: COMPLETED
Phase: N/A

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Status: UNKNOWN
Phase: PHASE1

Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia

Status: COMPLETED
Phase: PHASE2

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Status: COMPLETED
Phase: PHASE1

D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

Status: UNKNOWN
Phase: PHASE2

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Status: COMPLETED
Phase: PHASE1/PHASE2

Personalized NK Cell Therapy in CBT

Status: RECRUITING
Phase: PHASE2

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Status: RECRUITING
Phase: PHASE4

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)

Status: TERMINATED
Phase: PHASE1

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Status: ENROLLING_BY_INVITATION
Phase: PHASE2

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Status: COMPLETED
Phase: PHASE2

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

Status: WITHDRAWN
Phase: PHASE2

Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)

Status: TERMINATED
Phase: PHASE1

Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

Status: COMPLETED
Phase: PHASE3

Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2